F2 and deep vein thrombosis: Martinelli et al.’s study found a strong link between oral contraceptive use and venous thrombosis, especially carriers of the prothrombin G20210A mutation [84] (OR 22.1 for cerebral vein thrombosis (CVT), 4.4 for deep vein thrombosis (DVT)).